FSH could potentially inhibit the adipogenesis signaling pathway and prevent hepatic steatosis by binding to FSHR on liver cells and downregulating the classic cAMP/PKA/CREB pathway or CREB pathway. The gene discussed is CREB1; the disease is Hepatic steatosis.